Editorial Board

Editor-in-Chief

Kimberly Yonkers, M.D., University of Massachusetts Medical School/U Mass Memorial Medical Center, Worcester, Mass.

Dr. Yonkers is Katz Family Chair, Department of Psychiatry, University of Massachusetts Medical School/U Mass Memorial Medical Center. She brings to the task of editing APA’s newest journal a broad and deep experience in research and clinical work. Her research includes investigations into the clinical course, etiopathology, and treatment of psychiatric disorders as they occur in women. A major component of this work includes investigations into the occurrence and treatment of illnesses in pregnancy and the postpartum period and across the menstrual cycle. This area, by its nature, cuts across disciplines and requires psychiatric expertise as well as knowledge in neuroscience and reproductive biology. Her work has also included determining optimal methods for screening and treating women for substance use problems when they are pregnant or postpartum.

In this video, Dr. Yonkers explains her vision for the journal.

Associate Editors

David L. Fogelson, M.D., University of California, Los Angeles

Dr. Fogelson is a graduate of Harvard Medical School and completed his psychiatry residency at UCLA. He then did a fellowship in psychopharmacology at McLean Hospital. He has been on faculty at UCLA since 1982, where he is now a Clinical Professor of Psychiatry and a lecturer to the residents in their advanced psychopharmacology seminar. He was the medical director of the UCLA family study of schizophrenia. For over 30 years he has led a monthly journal club for the UCLA Clinical Research Faculty. He has a busy private practice in which he has seen over 10,000 patients, with well over 1000 having been bipolar. In his private practice he specializes in the diagnosis and treatment of psychoses, mood disorders, and anxiety disorders. He is an expert psychopharmacologist and also offers “eclectic” psychotherapy. He is an advocate of theory of mind and mentalization-based psychotherapy.

Ariadna Forray, M.D., Yale New Haven Hospital, New Haven, Conn.

Dr. Forray is a psychiatrist who treats medical and surgical patients at Yale New Haven Hospital who have psychiatric needs. She specializes in psychiatric and substance-use disorders in unique and complex patient populations that include pregnant and postpartum women, and adults living with sickle cell disease. One of the few psychiatrists in the U.S. with expertise in mental health issues in patients with sickle cell disease, Dr. Forray was recruited in 2012 as the psychiatry director of a newly developed, interdisciplinary Yale Medicine Adult Sickle Cell Program, which successfully transitioned care from high-cost inpatient and emergency care to integrated outpatient services and led to improved care and services. Dr. Forray also has a keen interest in mental health in women across the reproductive lifespan, which she says was inspired by an experience during her residency, when a patient was transferred to the ICU following an intentional overdose. The case inspired her to learn more about why only some postpartum women develop mental health issues, what role hormones might play, and how such struggles might impact a newborn infant. In addition, Dr. Forray is the director of the Center for Well-being of Women and Mothers, a reproductive psychiatry research program at Yale, where she studies novel treatments for perinatal substance use. She is currently working on a study that is evaluating two models to help obstetrical providers deliver substance-use treatment to pregnant women with an opioid use disorder across 12 sites in Connecticut and Massachusetts.

Amir Garakani, M.D., Greenwich Hospital, Greenwich, Conn.

Dr. Garakani is Chair of Psychiatry and Behavioral Health at Greenwich Hospital in Greenwich, CT. He was formerly Director of Education and an Attending Staff Psychiatrist in the Transitional Living Program at Silver Hill Hospital in New Canaan, CT. He is Board-Certified in Psychiatry, Forensic Psychiatry and Addiction Medicine. He received his B.A. in Classics (Latin), cum laude, with Distinction in All Subjects, from Cornell University, in Ithaca, NY, and his M.D. from the SUNY Upstate Medical University in Syracuse, NY, where he won the AMA Rock Sleyster Scholarship. He completed his psychiatry residency at the Mount Sinai Medical Center in New York, NY, and a research fellowship at the Mood and Anxiety Disorders Program at the Mount Sinai School of Medicine. Dr. Garakani also completed a fellowship in Forensic Psychiatry at New York University Medical Center. He has won several awards including the American Psychiatric Association (APA)/Lilly Resident Research Award, APA – NY County District Branch Resident Research Award, and travel awards from the Anxiety Disorders Association of America and Society of Biological Psychiatry. He also was an APA/GlaxoSmithKline Leadership Fellow and a Fellow of the Group for the Advancement of Psychiatry. He has participated in NIMH-funded research and is first or co-author on over 80 peer-reviewed papers and book chapters. He has taught classes to Mount Sinai medical students and residents on psychopharmacology, phenomenology, neuroscience and forensic psychiatry, and supervised psychiatry residents and medical students. He previously was elected to the Executive Council of the APA NY County District Branch. He is a Distinguished Fellow of the American Psychiatric Association and a Member of the American College of Psychiatrists. He is also a member of the Group for the Advancement of Psychiatry. He is also on the editorial board as a Clinical Case Discussion Editor for the Journal of Psychiatric Practice and an Associate Editor for Frontiers in Psychiatry - Psychopharmacology.

Robert H. Howland, M.D., University of Pittsburgh School of Medicine, Pittsburgh, Pa.

Dr. Howland is Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine; staff psychiatrist at the UPMC Western Psychiatric Hospital in Pittsburgh, Pennsylvania; and Research Associate at the VA Pittsburgh HealthCare System. He received his Bachelor of Science degree in Biomedical Engineering from Boston University; graduated from the University of Minnesota School of Medicine; and completed his residency training in general psychiatry and a Post-Doctoral Research Fellowship at the University of Pittsburgh. He is board-certified in general adult psychiatry and geriatric psychiatry. Dr. Howland is Co-Editor-in-Chief for the peer-reviewed journal Patient Related Outcome Measures; is an Associate Editor for the peer-reviewed journals Frontiers in Psychiatry: Psychopharmacology and Frontiers in Psychiatry: Psychological Therapy and Psychosomatics; and serves as Newsletter Editor for the Newsletter of the Society of Biological Psychiatry. He has authored or coauthored more than 300 peer-reviewed articles, book chapters, and other publications, and has been an investigator on numerous funded clinical research studies. Dr. Howland is a Distinguished Life Fellow of the American Psychiatric Association. His clinical and research interests have included the use of psychopharmacology, psychotherapy, neurostimulation therapies, and other novel therapies in the treatment of mood disorders, with a particular emphasis on chronic and treatment resistant forms of depression. In addition to his clinical, research and teaching activities at the University of Pittsburgh, he also has worked part-time in various community mental health programs throughout Western Pennsylvania.

Katharine A. Phillips, M.D., Weill Cornell Medical College, Cornell University, New York

Dr. Phillips is Professor of Psychiatry at Weill Cornell Medical College and an Attending Psychiatrist at New York-Presbyterian Hospital in New York City. She is also Residency Research Director for the Department of Psychiatry at Weill Cornell Medical College. In addition, she is Adjunct Professor of Psychiatry and Human Behavior at the Alpert Medical School of Brown University. Dr. Phillips is internationally recognized for her pioneering research studies and clinical expertise in body dysmorphic disorder as well as other obsessive-compulsive and related disorders. Her research studies on body dysmorphic disorder were continuously funded by the National Institute of Mental Health for more than 20 years. Dr. Phillips has received numerous honors and awards for her research, research mentoring, and other academic accomplishments, including a Special Presidential Commendation from the American Psychiatric Association for her research accomplishments. Dr. Phillips has more than 320 publications (scientific articles, book chapters, letters) and has authored or edited 11 books. She has given more than 550 presentations in the United States and abroad. She is on the scientific advisory boards of the American Society of Clinical Psychopharmacology, the Anxiety and Depression Association of America, and the International OCD Foundation. She is on the Board of Directors of The Canadian Institute for Obsessive Compulsive Disorders. She also serves on a number of editorial boards. From 2007 to 2013, Dr. Phillips was Chair of the DSM-5 Work Group on Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic, and Dissociative Disorders and a member of the DSM-5 Task Force; she is currently a member of the DSM Review Committee for Internalizing Disorders. From 2002 to 2006, she chaired the National Institute of Mental Health’s Interventions Research Review Committee (Scientific Review Group). Dr. Phillips is a Fellow of the American College of Neuropsychopharmacology, a member of the American College of Psychiatrists, and a Distinguished Fellow of the American Psychiatric Association. She has repeatedly been included in Best Doctors in America, Castle Connolly’s America’s Top Doctors, Who’s Who in America, and Who’s Who in the World.

Adrian Preda, M.D., DFAPA, University of California, Irvine, School of Medicine, Irvine, Calif.

Dr. Preda is a professor of clinical psychiatry and human behavior at the University of California, Irvine, School of Medicine, and recently was named Editor in Chief of Psychiatric News. An academic psychiatrist, Preda attended the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania, and completed his residency at Yale University School of Medicine. He served as chief resident in psychiatry at Yale before joining the Yale School of Medicine faculty as an Assistant Professor of Psychiatry. During his time at Yale, Dr. Preda conducted research on prodromal schizophrenia, diffusion tensor MRI and rTMS. Following Yale, Dr. Preda took on several roles with the UT Southwestern and the VA North Texas Health Care System in Dallas, including medical director of mental health triage and the Director of National Clozapine Center. He has been at the University of California, Irvine, School of Medicine since 2006 and has served in multiple positions at the institution, including director of residency training in psychiatry and vice chair of education in psychiatry and human behavior. His research at UC Irvine has been focused on the use of brain imaging and genetic biomarkers to improve validation of clinical trial outcomes in schizophrenia and Alzheimer’s dementia. Focusing his career on research and academia, Preda published studies in numerous journals. He received a NARSAD Young Investigator Award and is currently an associate editor of Frontiers in Psychiatry, Frontiers in Neuroscience, and Frontiers in Neuropsychopharmacology. He is section editor of psychiatry of EBSCO’s DynaMed and associate editor of Cochrane Clinical Answers. He is the editor-in-chief of StatPearls’ Geriatric Psychiatry, Consultation Liaison, and Medical Students Psychiatry. He has also written for Psychology Today and PLOS Mind the Brain. Preda is a faculty member of the Faculty of 1000 and an APA Distinguished Fellow.

H. Paul Putman III, M.D., F.A.C.Psych., Austin, Tex.

Dr. Putman earned his BA in Biology at Austin College in Sherman, Texas, and received his MD from the University of Texas Medical Branch at Galveston. He completed his internship and residency in General Psychiatry at the Medical University of South Carolina in Charleston, where he was Chief Resident. He is Board Certified in General Psychiatry by the American Board of Psychiatry and Neurology. A practicing psychiatrist for over thirty years, he has also performed Phase I-IV studies in psychopharmacology, published in peer reviewed journals, served as a supervisor for the Austin Graduate Medical Education/UT Medical Branch Residency Program in Psychiatry, and lectured in the psychiatry departments of University of Texas Houston McGovern School of Medicine and The University of Texas at Austin Dell Medical School. In addition to psychiatry, Dr. Putman has a background in journalism and editing. He has served on the Editorial Board of The Jefferson Journal of Psychiatry and contributes often to Psychiatric News on topics consistent with enhancing scholarly practice. He is currently completing his third book for American Psychiatric Association (APA) Publishing, Reducing Cognitive Errors in Psychiatric Practice. His first, Rational Psychopharmacology: A Book of Clinical Skills (a text on practicing clinical psychopharmacology) was followed by Encountering Treatment Resistance: Solutions through Reconceptualization (which details how practitioners’ concept formation and problem solving approaches determine clinical outcomes). Clinicians represent the anchor leg of translational medicine, and Dr. Putman works to raise the level of clinical practice by reinforcing how a scholarly approach to the scientific literature enhances clinical outcomes for patients. Dr. Putman is a Distinguished Life Fellow of the APA and a Fellow and former Laughlin Fellow of the American College of Psychiatrists (ACP). A past President of the Central (now American) Neuropsychiatric Association, he has served the APA as chair of its Committee of Residents and as an original member of its Committee of Early Career Psychiatrists. He recently served the ACP as chair of its Continuing Education Committee.

Dinesh Sangroula, M.D., Atrium Health-Wake Forest School of Medicine, Charlotte, N.C.

Dr. Sangroula is an American Board of Psychiatry and Neurology (ABPN)-Certified General and Child & Adolescent Psychiatrist. He currently serves as a Clinical Assistant Professor of Psychiatry at Atrium Health-Wake Forest School of Medicine in Charlotte, North Carolina. His expertise spans the evaluation and treatment of children, adolescents, and young adults with a diverse range of psychiatric conditions including ADHD, Oppositional Defiant Disorder, DMDD, Autism Spectrum Disorder, Mood Disorders, Anxiety Disorders, Psychotic Disorders, and OCD, among others. Originally from Nepal, Dr. Sangroula graduated from Kathmandu University. He began his medical career as a general practitioner in rural areas of Nepal for four years, an experience that fueled his passion for psychiatry. He pursued further training as a research scholar at Northwell Health-Zucker Hillside Hospital, N.Y., specializing in child and adolescent psychiatry. He then completed his psychiatry residency training at Jamaica Hospital Medical Center, N.Y., where he distinguished himself by winning 2nd place and 1st place in the annual New York State Psychiatric Association best resident research paper contest in 2017 and 2018, respectively. Further honing his expertise, Dr. Sangroula completed a fellowship in child and adolescent psychiatry at Geisel School of Medicine-Dartmouth Hitchcock Medical Center, NH, in 2021. In addition to his clinical responsibilities, Dr. Sangroula is actively engaged in teaching medical students and residents, both in clinical settings and through research projects. He leads a two-month psychiatry observership program for international medical graduates at Atrium Health, providing mentorship in both clinical and research endeavors. His research interests encompass a broad spectrum of psychiatric illnesses, with a particular focus on child and adolescent psychiatry. He has authored numerous meta-analyses, systematic reviews, retrospective studies, and case reports published in esteemed peer-reviewed journals.

Susan K. Schultz, M.D., James Haley VA Hospital, Tampa, Fla.

Dr. Schultz is a geriatric psychiatrist on the Mental Health and Behavioral Science Service, James Haley VA Hospital, Tampa. Previously, Dr. Schultz was Director of the Aging Mind and Brain Initiative, Professor of Psychiatry at the University of Iowa Carver College of Medicine, Vice-Chair for Clinical Translation, and Director of the Iowa Geriatric Education Center. She has been President of the American Association for Geriatric Psychiatry, is a Distinguished Fellow of the American Psychiatric Association, and has board qualifications in Geriatric Psychiatry and Psychosomatic Medicine. She serves on NIH study sections, the FDA Psychopharmacologic Drugs Advisory Committee, is a deputy editor for the American Journal of Psychiatry. She also served as the text editor for DSM-5. Her present research involves studying the brain changes seen in Alzheimer’s disease through brain imaging and other biological markers, including pre-symptomatic Alzheimer’s disease. She has conducted PET and MRI neuroimaging research and experimental treatment studies for Alzheimer’s disease through collaboration with the Alzheimer’s Disease Cooperative Study (ADCS).

Sandarsh Surya, M.B.B.S., Medical College of Georgia at Augusta University, Augusta, Ga.

Dr. Surya is Associate Professor, Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University. He is a psychiatrist with expertise in geriatric psychiatry and therapeutic brain stimulation. He is an Associate Professor in the Department of Psychiatry and Health Behavior at the Medical College of Georgia at Augusta University. He received his medical degree from Bangalore, India, his training included Residency in Psychiatry at Augusta University (Chief Resident) and a Fellowship in Geriatric Psychiatry from Western Psychiatric Institute and Clinic. His clinical and research interests are geriatric psychiatry and therapeutic brain stimulation in psychiatry. His clinical activities include Medical Director, ECT service, Augusta University Medical Center; Geriatric psychiatry and treatment-resistant depression outpatient clinics, Augusta University Medical Center; and Supervisor for psychiatry residents in outpatient services in schizophrenia and mood disorder clinics. Dr. Surya is a passionate educator and mentor, and he enjoys teaching medical students, residents, and fellows. He is an active member of the American Psychiatric Association and International Society of ECT and Neurostimulation. He has experience designing and conducting clinical trials, in areas like ECT for depression, ECT and clozapine use in serious mental illness. He has published several articles in peer-reviewed journals and presented his research at national and international conferences.

Editorial Staff

Simone Taylor, Ph.D.
Publisher

Michael Roy
Executive Editor, Journals

Contact the Journal

To reach our editorial office, contact:

Psychiatric Research and Clinical Practice
800 Maine Avenue, S.W., Suite 900
Washington, D.C. 20024
Phone: 800-368-5777, 202-459-9722
Fax: 202-403-3094
E-mail: [email protected]

For technical support, visit our Help page.

To send us feedback about our website, visit the Contact Us page.